Literature DB >> 28430973

Biological functions of fucose in mammals.

Michael Schneider1, Esam Al-Shareffi1,2, Robert S Haltiwanger1,3.   

Abstract

Fucose is a 6-deoxy hexose in the l-configuration found in a large variety of different organisms. In mammals, fucose is incorporated into N-glycans, O-glycans and glycolipids by 13 fucosyltransferases, all of which utilize the nucleotide-charged form, GDP-fucose, to modify targets. Three of the fucosyltransferases, FUT8, FUT12/POFUT1 and FUT13/POFUT2, are essential for proper development in mice. Fucose modifications have also been implicated in many other biological functions including immunity and cancer. Congenital mutations of a Golgi apparatus localized GDP-fucose transporter causes leukocyte adhesion deficiency type II, which results in severe developmental and immune deficiencies, highlighting the important role fucose plays in these processes. Additionally, changes in levels of fucosylated proteins have proven as useful tools for determining cancer diagnosis and prognosis. Chemically modified fucose analogs can be used to alter many of these fucose dependent processes or as tools to better understand them. In this review, we summarize the known roles of fucose in mammalian physiology and pathophysiology. Additionally, we discuss recent therapeutic advances for cancer and other diseases that are a direct result of our improved understanding of the role that fucose plays in these systems.
© The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  cancer; development; fucose; fucosyltransferase; immunology

Mesh:

Substances:

Year:  2017        PMID: 28430973      PMCID: PMC5458543          DOI: 10.1093/glycob/cwx034

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  266 in total

1.  Correction of leukocyte adhesion deficiency type II with oral fucose.

Authors:  T Marquardt; K Lühn; G Srikrishna; H H Freeze; E Harms; D Vestweber
Journal:  Blood       Date:  1999-12-15       Impact factor: 22.113

2.  Mice lacking alpha1,3-fucosyltransferase IX demonstrate disappearance of Lewis x structure in brain and increased anxiety-like behaviors.

Authors:  Takashi Kudo; Takashi Fujii; Shiro Ikegami; Kaoru Inokuchi; Yuko Takayama; Yuzuru Ikehara; Shoko Nishihara; Akira Togayachi; Satoru Takahashi; Kouichi Tachibana; Shigeki Yuasa; Hisashi Narimatsu
Journal:  Glycobiology       Date:  2006-09-14       Impact factor: 4.313

3.  Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male.

Authors:  D P O'Brien; K M Gale; J S Anderson; J H McVey; G J Miller; T W Meade; E G Tuddenham
Journal:  Blood       Date:  1991-07-01       Impact factor: 22.113

4.  Alterations in the serum glycome due to metastatic prostate cancer.

Authors:  Zuzana Kyselova; Yehia Mechref; Mohammad M Al Bataineh; Lacey E Dobrolecki; Robert J Hickey; Jake Vinson; Christopher J Sweeney; Milos V Novotny
Journal:  J Proteome Res       Date:  2007-04-14       Impact factor: 4.466

5.  Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia/lymphoma.

Authors:  Toshihiko Ishii; Takashi Ishida; Atae Utsunomiya; Atsushi Inagaki; Hiroki Yano; Hirokazu Komatsu; Shinsuke Iida; Kazunori Imada; Takashi Uchiyama; Shiro Akinaga; Kenya Shitara; Ryuzo Ueda
Journal:  Clin Cancer Res       Date:  2010-02-16       Impact factor: 12.531

6.  Tumor-microenvironment interactions: the fucose-generating FX enzyme controls adhesive properties of colorectal cancer cells.

Authors:  Adi Zipin; Mira Israeli-Amit; Tsipi Meshel; Orit Sagi-Assif; Ilana Yron; Veronica Lifshitz; Eran Bacharach; Nechama I Smorodinsky; Ariel Many; Peter A Czernilofsky; Donald L Morton; Isaac P Witz
Journal:  Cancer Res       Date:  2004-09-15       Impact factor: 12.701

7.  Oligosaccharides containing fucose linked alpha(1-3) and alpha(1-4) to N-acetylglucosamine cause decompaction of mouse morulae.

Authors:  J M Bird; S J Kimber
Journal:  Dev Biol       Date:  1984-08       Impact factor: 3.582

Review 8.  Emerging principles for the therapeutic exploitation of glycosylation.

Authors:  Martin Dalziel; Max Crispin; Christopher N Scanlan; Nicole Zitzmann; Raymond A Dwek
Journal:  Science       Date:  2014-01-03       Impact factor: 47.728

9.  Marketing approval of mogamulizumab: a triumph for glyco-engineering.

Authors:  Alain Beck; Janice M Reichert
Journal:  MAbs       Date:  2012-07-01       Impact factor: 5.857

10.  Mutations in multidomain protein MEGF8 identify a Carpenter syndrome subtype associated with defective lateralization.

Authors:  Stephen R F Twigg; Deborah Lloyd; Dagan Jenkins; Nursel E Elçioglu; Christopher D O Cooper; Nouriya Al-Sannaa; Ali Annagür; Gabriele Gillessen-Kaesbach; Irina Hüning; Samantha J L Knight; Judith A Goodship; Bernard D Keavney; Philip L Beales; Opher Gileadi; Simon J McGowan; Andrew O M Wilkie
Journal:  Am J Hum Genet       Date:  2012-10-11       Impact factor: 11.025

View more
  79 in total

1.  The SH3 domain in the fucosyltransferase FUT8 controls FUT8 activity and localization and is essential for core fucosylation.

Authors:  Seita Tomida; Misaki Takata; Tetsuya Hirata; Masamichi Nagae; Miyako Nakano; Yasuhiko Kizuka
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

Review 2.  α-L-Fucosidases and their applications for the production of fucosylated human milk oligosaccharides.

Authors:  Li Wan; Yingying Zhu; Wenli Zhang; Wanmeng Mu
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-01       Impact factor: 4.813

3.  Pathogenic Variants in Fucokinase Cause a Congenital Disorder of Glycosylation.

Authors:  Bobby G Ng; Jill A Rosenfeld; Lisa Emrick; Mahim Jain; Lindsay C Burrage; Brendan Lee; William J Craigen; David R Bearden; Brett H Graham; Hudson H Freeze
Journal:  Am J Hum Genet       Date:  2018-11-29       Impact factor: 11.025

4.  Biallelic Mutations in FUT8 Cause a Congenital Disorder of Glycosylation with Defective Fucosylation.

Authors:  Bobby G Ng; Gege Xu; Nandini Chandy; Joan Steyermark; Deepali N Shinde; Kelly Radtke; Kimiyo Raymond; Carlito B Lebrilla; Ali AlAsmari; Sharon F Suchy; Zöe Powis; Eissa Ali Faqeih; Susan A Berry; David F Kronn; Hudson H Freeze
Journal:  Am J Hum Genet       Date:  2018-01-04       Impact factor: 11.025

Review 5.  Direct Visualization of Live Zebrafish Glycans via Single-Step Metabolic Labeling with Fluorophore-Tagged Nucleotide Sugars.

Authors:  Senlian Hong; Pankaj Sahai-Hernandez; Digantkumar Gopaldas Chapla; Kelley W Moremen; David Traver; Peng Wu
Journal:  Angew Chem Int Ed Engl       Date:  2019-08-28       Impact factor: 15.336

6.  hFUT1-Based Live-Cell Assay To Profile α1-2-Fucoside-Enhanced Influenza Virus A Infection.

Authors:  Senlian Hong; Geramie Grande; Chenhua Yu; Digantkumar G Chapla; Natalie Reigh; Jeong-Yeh Yang; Yi Yang; Ken Izumori; Kelley W Moremen; Jia Xie; Peng Wu
Journal:  ACS Chem Biol       Date:  2020-04-09       Impact factor: 5.100

7.  ADAMTS9 and ADAMTS20 are differentially affected by loss of B3GLCT in mouse model of Peters plus syndrome.

Authors:  Bernadette C Holdener; Christopher J Percival; Richard C Grady; Daniel C Cameron; Steven J Berardinelli; Ao Zhang; Sanjiv Neupane; Megumi Takeuchi; Javier C Jimenez-Vega; Sardar M Z Uddin; David E Komatsu; Robert Honkanen; Johanne Dubail; Suneel S Apte; Takashi Sato; Hisashi Narimatsu; Steve A McClain; Robert S Haltiwanger
Journal:  Hum Mol Genet       Date:  2019-12-15       Impact factor: 6.150

8.  Fucosyltransferase Induction during Influenza Virus Infection Is Required for the Generation of Functional Memory CD4+ T Cells.

Authors:  Roberto Tinoco; Florent Carrette; Monique L Henriquez; Yu Fujita; Linda M Bradley
Journal:  J Immunol       Date:  2018-02-28       Impact factor: 5.422

9.  Cryogenic IR spectroscopy combined with ion mobility spectrometry for the analysis of human milk oligosaccharides.

Authors:  Neelam Khanal; Chiara Masellis; Michael Z Kamrath; David E Clemmer; Thomas R Rizzo
Journal:  Analyst       Date:  2018-04-16       Impact factor: 4.616

10.  Impact of Protein Glycosylation on the Design of Viral Vaccines.

Authors:  Kathleen Schön; Bernd Lepenies; Guillaume Goyette-Desjardins
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.